HZ-R078

N/A

Report date: 2023/08/24 17:05:43
NME

Base Information

Drug NameHZ-R078
Drug Alias NameN/A
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionSignal transducer and activator of transcription 3 degraders
TargetsSignal transducer and activator of transcription 3
Therapy Area/IndicationsLymphoma, T-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHeaZen Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHeaZen Therapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsLymphoma, T-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A